Madrigal Pharmaceuticals (MDGL)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Madrigal Pharmaceuticals (MDGL) since 2023: 0 buys and 1 sale. The most recent was disclosed on May 19, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at MDGL
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
MDGL: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP reported buying shares
5 reported purchases of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
MDGL: third_quarter 2026 lobbying report
FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
Public: Oct 20, 2026, 3:55 PM EDTOriginal source ↗MDGL: third_quarter 2026 lobbying report
Issues related to CMMI drug pricing; 340B drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing
Public: Oct 19, 2026, 3:46 PM EDTOriginal source ↗MDGL: third_quarter 2026 lobbying report
Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Section 301 tariffs. Issues related to CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); GENEROUS Medicaid Drug Pricing Model.
Public: Oct 19, 2026, 11:29 AM EDTOriginal source ↗MDGL: third_quarter 2026 lobbying report
Advocacy related to prescription drug access and pricing.
Public: Oct 18, 2026, 2:08 PM EDTOriginal source ↗
Who traded MDGL
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01May 19, 2023
All trades
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Madrigal Pharmaceuticals MDGL
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.